comparemela.com

Latest Breaking News On - Lupin inc - Page 5 : comparemela.com

Pharmaceutical Company Sues Lupin for Patent Infringement

What K Street is paying attention to this month

What K Street is paying attention to this month
politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.

IP Forecast: Ferring, Lupin To Face Off In Clenpiq Patent Trial

Ferring Pharmaceuticals is scheduled to go head-to-head with generic drugmaker Lupin in a Delaware bench trial next week over patents connected to the first U.S. Food and Drug Administration-approved prescription "ready-to-drink" colon cleanser plus all the other major intellectual property matters that are on deck for the coming week.

Mosquito-borne Disease Mitigation Centers Around Antiviral Therapy: Study

Published: Mar 08, 2021 Investments towards research of live attenuated vaccines for mosquito-borne disease treatments in major population centers is generating better prospects for sales. Fact.MR Rockville, MD: An ongoing report on the mosquito-borne disease treatments market by market research firm Fact.MR has projected positive growth prospects for 2021. The covid-19 pandemic has moderately impacted the industry owing to the redirection of healthcare facilities towards the new threat of the coronavirus. However, continued concerns over vector-borne disease is expected to sustain steady growth in the market in the coming years. According to the World Mosquito Program, close to 700 million people globally contract mosquito borne ailments annually, which results in approximately a million deaths. In recent years, dengue cases have risen strongly and 40 percent of the global population is considered to be at risk, with around 25,000 patients succumbing to the disease annually.

iBio (IBIO) Q2 2021 Earnings Call Transcript

iBio (IBIO) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.